Volume 6 Issue 3
Jul.  2026
Turn off MathJax
Article Contents
Zhiyuan Du, Kexin Wang, Zijia Liu, Yifei Wang, Bosi Sun, Yu Wang, Chenchen Yin, Tianjiao Zhao, Dan Yin, Ajiao Yu, Weijun Li, Yang Qu, Yu Liu, Lei Wang, Lei Jiao, Baofeng Yang. Therapeutic effects of Naoshuan Kangfu Capsule on post-stroke spasticity in normothermic and cold-exposed rat models[J]. Frigid Zone Medicine, 2026, 6(3): 150-165. doi: 10.1515/fzm-2026-0016
Citation: Zhiyuan Du, Kexin Wang, Zijia Liu, Yifei Wang, Bosi Sun, Yu Wang, Chenchen Yin, Tianjiao Zhao, Dan Yin, Ajiao Yu, Weijun Li, Yang Qu, Yu Liu, Lei Wang, Lei Jiao, Baofeng Yang. Therapeutic effects of Naoshuan Kangfu Capsule on post-stroke spasticity in normothermic and cold-exposed rat models[J]. Frigid Zone Medicine, 2026, 6(3): 150-165. doi: 10.1515/fzm-2026-0016

Therapeutic effects of Naoshuan Kangfu Capsule on post-stroke spasticity in normothermic and cold-exposed rat models

doi: 10.1515/fzm-2026-0016
Funds:

the Natural Science Foundation of China 82270273

the Joint Fund of the National Natural Science Foundation of China grant no. U25A201915

More Information
  •   Objective  Post-stroke spasticity (PSS), a common and debilitating complication after stroke, severely impacts patients' motor function and quality of life. Naoshuan Kangfu Capsule (NSKF) is traditionally used for the treatment of stroke, hemiplegia, aphasia, and facial paralysis caused by blood stasis obstructing collaterals; however, its therapeutic effects and underlying mechanisms in PSS remain unclear. This study investigated the protective and reparative effects of NSKF on PSS following cerebral ischemia under both normal and cold exposure conditions.  Methods  A global cerebral ischemia model was established in rats using bilateral two-vessel occlusion (2VO). PSS was evaluated using behavioral assessments, including the modified Neurological Severity Score (mNSS), balance beam test, Ashworth Scale, and sticky dot test, in 2VO rats maintained under normal and cold temperature conditions. Hematoxylin-eosin (HE) staining was used to assess cerebral histomorphological changes. RNA sequencing was conducted to identify differentially expressed genes in brain tissues. Cerebral cortex tissue neuron-specific enolase (NSE), brain vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), glutamate (Glu), and γ-aminobutyric acid (GABA) levels were measured using ELISA. qRT-PCR was used to determine the mRNA expression levels of Grm1a, Gabbr1, Interleukin-1β (IL-1β), Interleukin-6 (IL-6), Interleukin-18 (IL-18), and tumor necrosis factor-α (TNF-α). Immunofluorescence staining was performed to assess ionized calcium-binding adaptor molecule 1(IBA-1) and cluster of differentiation 31 (CD31) expression. Apoptosis was evaluated using TUNEL staining and Caspase-3 assay.  Results  NSKF significantly alleviated PSS in 2VO rats at 5 and 10 weeks after cerebral ischemia, as evidenced by multiple behavioral assessments, with effects comparable to those of the positive control drug Baclofen. NSKF suppressed NSE and IBA-1 activation, indicating attenuation of neuronal injury and neuroinflammation. RNA sequencing revealed that NSKF regulated pathways associated with apoptosis, angiogenesis, and inflammatory responses. Subsequent validation confirmed that NSKF inhibited neuronal apoptosis, as evidenced by reduced cell death and caspase-3 activity, while promoting angiogenesis through increased CD31 and VEGF expression. In addition, NSKF modulated neurotransmitter homeostasis by decreasing cortical Glu/GABA levels, and upregulating the expression of metabotropic glutamate receptor 1a (Grm1a) and GABA B receptor 1 (Gabbr1). However, NSKF did not significantly affect neuronal proliferation. Furthermore, NSKF suppressed neuroinflammation by reducing IBA-1 activation and pro-inflammatory cytokine expression (IL-1β, IL-6, IL-18, and TNF-α), potentially through inhibition of the NF-κB signaling pathway. Notably, NSKF maintained its therapeutic efficacy against PSS in 2VO rats exposed to chronic cold conditions. Long-term administration of NSKF (50, 400, 800, and 1600 mg/kg for 10 weeks) produced no observable toxic effects.  Conclusions  NSKF improves neurological deficits and alleviates post-stroke spasticity after cerebral ischemic injury by reducing neuronal apoptosis, enhancing angiogenesis, suppressing neuroinflammation, and restoring Glu/GABA neurotransmitter balance. Its sustained efficacy under cold exposure conditions suggests potential advantages for patients living in cold environments. These findings provide experimental evidence for the therapeutic potential of NSKF as a candidate intervention for post-stroke spasticity.

     

  • loading
  • [1]
    Saini V, Guada L, Yavagal D R. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology, 2021; 97(20 Suppl 2): S6-S16.
    [2]
    Fladt J, Ospel J M, Singh N, et al. Optimizing patient-centered stroke care and research in the prehospital setting. Stroke, 2023; 54(9): 2453-2460. doi: 10.1161/STROKEAHA.123.044169
    [3]
    Wissel J, Manack A, Brainin M. Toward an epidemiology of poststroke spasticity. Neurology, 2013; 80: S13-S19. doi: 10.1212/WNL.0b013e318279755f
    [4]
    Li S, Francisco G E. New insights into the pathophysiology of poststroke spasticity. Front Hum Neurosci, 2015; 9: 192.
    [5]
    Sun X, Cai J, Zhang A, et al. Electroacupuncture pretreatment alleviates post-stroke spasticity in rats by inhibiting NF-κB/NLRP3 signaling pathway-mediated inflammation and neuronal apoptosis. Nan Fang Yi Ke Da Xue Xue Bao, 2024; 44: 2102-2109.
    [6]
    Nguyen J N, Mohan E C, Pandya G, et al. CD13 facilitates immune cell migration and aggravates acute injury but promotes chronic poststroke recovery. J Neuroinflammation, 2023; 20: 232. doi: 10.1186/s12974-023-02918-3
    [7]
    Flores A E, Pascotini E T, Kegler A, et al. Worst spasticity in patients post-stroke associated with MNSOD ALA16VAL polymorphism and interleukin-1β. Gene, 2022; 847: 146880. doi: 10.1016/j.gene.2022.146880
    [8]
    Wang J X, Fidimanantsoa O L, Ma L X. New insights into acupuncture techniques for poststroke spasticity. Front Public Health, 2023; 11: 1155372. doi: 10.3389/fpubh.2023.1155372
    [9]
    Alahmad B, Khraishah H, Royé D, et al. Associations between extreme temperatures and cardiovascular cause-specific mortality: Results from 27 countries. Circulation, 2023; 147: 35-46. doi: 10.1161/CIRCULATIONAHA.122.061832
    [10]
    Vickneson K, Blackburn J, Gallagher J R, et al. Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia. Diabetologia, 2021; 64: 1436-1441. doi: 10.1007/s00125-021-05425-3
    [11]
    Shepherd A J, Mohapatra D P. Attenuation of unevoked mechanical and cold pain hypersensitivities associated with experimental neuropathy in mice by angiotensin Ⅱ type-2 receptor antagonism. Anesth Analg, 2019; 128: e84-e87. doi: 10.1213/ANE.0000000000003857
    [12]
    Chen Z, Liu P, Xia X, et al. The underlying mechanisms of cold exposure-induced ischemic stroke. Sci Total Environ, 2022; 834: 155514. doi: 10.1016/j.scitotenv.2022.155514
    [13]
    Papuć E, Rejdak K. Increased cerebrospinal fluid S100B and NSE reflect neuronal and glial damage in Parkinson's disease. Front Aging Neurosci, 2020; 12: 156. doi: 10.3389/fnagi.2020.00156
    [14]
    Isgrò M A, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: Biochemical and clinical aspects. Adv Exp Med Biol, 2015; 867: 125-143.
    [15]
    Liu J, Zhao G, Niu Y, et al. Effect of electro-acupuncture therapy on limb spasm and excitability of motor neurons in stroke rats. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2021; 50: 361-368.
    [16]
    Zhou P, Xie W, Meng X, et al. Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells, 2019; 8(3): 213. doi: 10.3390/cells8030213
    [17]
    Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther, 2020; 207: 107452. doi: 10.1016/j.pharmthera.2019.107452
    [18]
    Sun L P, Shi F F, Zhang W W, et al. Antioxidant and antiinflammatory activities of safflower (Carthamus tinctorius L. ) honey extract. Foods, 2020; 9(8): 1039. doi: 10.3390/foods9081039
    [19]
    Haque Bhuiyan M M, Mohibbullah M, Hannan M A, et al. The neuritogenic and synaptogenic effects of the ethanolic extract of radix Puerariae in cultured rat hippocampal neurons. J Ethnopharmacol, 2015; 173: 172-182. doi: 10.1016/j.jep.2015.07.013
    [20]
    Wu L, Song H, Zhang C, et al. Efficacy and safety of panax notoginseng saponins in the treatment of adults with ischemic stroke in China: A randomized clinical trial. JAMA Netw Open, 2023; 6: e2317574. doi: 10.1001/jamanetworkopen.2023.17574
    [21]
    Lin J, Wang Q, Zhou S, et al. Tetramethylpyrazine: A review on its mechanisms and functions. Biomed Pharmacother, 2022; 150: 113005. doi: 10.1016/j.biopha.2022.113005
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(9)

    Article Metrics

    Article views (76) PDF downloads(19) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return